BioHealth News Archive
SBIR Road Tour Coming to UMD- Last Chance to Register!
College Park, Maryland, will serve as a SBIR Road Tour stop for the state of Maryland, and will provide attendees with an opportunity to…
Read More
America’s Most Innovative Leaders: 24 healthcare leaders on the list
Forbes released its annual list of the country's most innovative leaders, comprising 100 founders and CEOs known for encouraging creative and highly successful innovation…
Read More
Johns Hopkins University announces new center for psychedelic research – ABC News
Johns Hopkins University is launching a new center for psychedelic research that will use psychedelic drugs to study the mind and therapies for diseases…
Read More
Machfu Awarded $1M Phase II Extension SBIR Grant from the Department of Energy | Business Wire
Machfu, an industrial Internet of Things technology company, announced today that it has been awarded the Small Business Innovation Research (SBIR) Phase II extension…
Read More
Versant backs new, medtech-focused Vensana Capital fund, launching with $225M | FierceBiotech
Vensana Capital—an independent, medtech-focused venture capital investment firm supported by Versant Ventures—has launched with a $225 million fund and ambitions to support new breakthroughs…
Read More
Children’s National and NCC-PDI Announce $150K NICU Medical Device Competition Finalists and Symposium Keynote Speakers | BioSpace
Organizers of the $150K "Make Your Medical Device Pitch for Kids!" competition today announced the 12 finalists who are advancing to the live pitch…
Read More
Downstream Processing of Complex Molecules, Pure and Simple
Making a therapeutic that contains biological components is just the start of creating a medicine. Then, biopharmaceutical companies must capture that drug and ensure…
Read More
Bristol-Myers teams with BioMotiv to build and buy biotechs | FierceBiotech
Bristol-Myers Squibb has allied with biotech accelerator BioMotiv. The deal sets Bristol-Myers up to found and fund biotechs with BioMotiv before going on to…
Read More
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
2019 CEO Outlook (life sciences cut) – KPMG United States
Low interest rates and high stock valuations are fueling U.S. life sciences CEOs’ growing appetite for mergers and acquisitions, KPMG’s CEO Outlook found. {iframe}https://home.kpmg/us/en/home/media/press-releases/2019/09/us-life-sciences-ceos-see-financial-drivers-as-catalyst-for-m-and-a-kpmg-poll.html{/iframe}
Read More
Key details in Viela Bio’s $150 million IPO – Washington Business Journal
It’s a pivotal moment for the MedImmune spinout, which has put the fate of its first prospective product in regulators' hands. {iframe}https://www.bizjournals.com/washington/news/2019/09/03/5-things-to-know-ahead-of-viela-bio-s-planned-150m.html{/iframe}
Read More
A Uniquely Positioned GMP BioManufacturing Facility Hits the Market in Maryland · BioBuzz
Biotech is booming across the country, especially in the top biotech clusters like Boston, San Francisco, New York and in the BioHealth Capital Region…
Read More
Biopharma jobs boom in Massachusetts, though challenges still exist | BioPharma Dive
Boosted by new research and development positions, Massachusetts last year experienced the fastest rate of biopharma job growth in a decade, according to a…
Read More
Children’s National Health System-HSC Health Care System merger gets regulatory approval – Washington Business Journal
The agreement is intended to create a system for children with rare and complex health conditions. {iframe}https://www.bizjournals.com/washington/news/2019/09/03/children-s-nationalhsc-merger-gets-regulatory.html?ana=e_ae_set3&j=89913611&t=Afternoon&mkt_tok=eyJpIjoiWWpObVpqZ3dOalkzTUdRMiIsInQiOiI3VUpvQTZwc0tidjAxT2ZuNTNcL0xNUGtqQ1RNdDBJSERFR3hrUDRRVU1OZ0JMemE3ZTV0XC9aYVhBNmtBS3lGZVVNelVWZGJsYjFuZXNOQ25JVHdCWlwvZTJ2RmcyUmx4ZHJFMkc3T0k3Zm9kaFZ0aDRwcldpZjF2dDhmeHBKXC80ZTAifQ%3D%3D{/iframe}
Read More
Emergent BioSolutions Awarded 10-Year HHS Contract to Deliver ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) Into the Strategic National Stockpile NYSE:EBS
In support of the U.S. government’s policy to maintain a stockpile to be able to protect every American from smallpox, Emergent BioSolutions Inc. (NYSE:…
Read More